[Cell Signaling Technology] Why antibody validation is crucial for SARS-CoV-2 research

To rapidly develop therapies and vaccines to combat the COVID-19 pandemic, scientists need answers to mechanistic questions about how the virus and host interact. In this video, Cell Signaling Technology Chief Scientific Officer Roberto Polakiewicz PhD discusses:

  • Key questions and research focus areas
  • How research antibodies can contribute to our understanding of the SARS-CoV-2 virus and the host immune response
  • Why scientific reproducibility and high-quality, verified research tools are as important as ever
  • How the CST scientific mission aligns with global efforts to fight the COVID-19 pandemic